Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and ...
Proceeds support ongoing all-comers Phase 1 trial of TM4SF1-directed Nuclear-Delivered ADC AGX101CAMBRIDGE, Mass., Nov. 17, ...
OncoNano Medicine, Inc. ("OncoNano") announces the appointment of Brent Sorrells as Chief Operating Officer. Bringing more ...
A new study published in eLife has found that a remarkably rare type of neuron acts as a master conductor for the brain’s ...
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...
Like all living things, bacteria adapt to survive. Over time, bacteria have been developing resistance to common antibiotics ...
Entrada Therapeutics reported a 3Q25 GAAP EPS loss of –$1.06 and revenue of $1.6 million, reflecting declining collaboration ...
A new study by Professor Ludmilla Aristilde and her team shows how soil microbes steer carbon flow to adapt and create ...
Unraveling mechanisms underlying post-acute SARS-CoV-2 sequelae (long COVID) and finding therapeutic solutions require a full understanding of the causative role of SARS-CoV-2 persistence and/or ...
Dissolved organic matter (DOM) is central to carbon and nutrient cycling in both natural and engineered environments. In ...